Brief: Cyxone signs agreement to buy Rabeximod

Cyxone AB

14/06/2017 08:04

June 14 (Reuters) - CYXONE AB  CYXO.ST  
    * SIGNS AGREEMENT ON EXCLUSIVE RIGHT TO ACQUIRE CLINICAL 
DRUG CANDIDATE RABEXIMOD FROM OXYPHARMA AB 
    * OXYPHARMA IS OFFERED 1,916,732 SHARES OF CYXONE AND 10 
PERCENT OF ROYALTY RIGHTS  ON FUTURE NET INCOME CONNECTED TO 
RABEXIMOD 
 
Source text for Eikon:  ID:nBQN7ncnFj  
Further company coverage:  CYXO.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))